Dr. Morris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Physicians Office Building 3 Dr
# 170
Chapel Hill, NC 27599Phone+1 919-483-7282
Education & Training
- University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2005 - 2008
- University of North Carolina HospitalsResidency, Internal Medicine, 2002 - 2005
- Case Western Reserve University School of MedicineClass of 2002
Certifications & Licensure
- NC State Medical License 2017 - 2025
Publications & Presentations
PubMed
- 26 citationsTrilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer:...Renata Ferrarotto, Ian Anderson, Balazs Medgyasszay, Maria Rosario García-Campelo, William Jeffery Edenfield
Cancer Medicine. 2021-09-01 - 49 citationsTrilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, pl...Davey B. Daniel, Vladimer Kuchava, Igor Bondarenko, Oleksandr Ivashchuk, Sreekanth Reddy
International Journal of Cancer. 2021-05-15 - 38 citationsEffects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results f...Jared Weiss, Jerome H. Goldschmidt, Z. Andric, Konstantin H. Dragnev, Chad Gwaltney
Clinical Lung Cancer. 2021-03-26
Press Mentions
- G1 Therapeutics Makes Key Appointments to Management TeamAugust 3rd, 2017
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: